Results

Total Results: over 10,000 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-non-muscle-invasive-bladder-cancer
    November 01, 2020 - , cystoscopy, urine cytology, urine-based biomarkers, transurethral resection of bladder tumor (TURBT … How do tumor characteristics (stage, grade, multiplicity, size, molecular and genetic alterations) predict … perhaps replace cytology and cystoscopy in the diagnosis and surveillance of patients with urothelial cancers … Genetic and epidemiological evidence indicates that African Americans may have a more aggressive form of malignancy … for 90% of all malignant tumors.
  2. qualityindicators.ahrq.gov/Downloads/Modules/IQI/v2021/TechSpecs/IQI_09_Pancreatic_Resection_Mortality_Rate.pdf
    July 01, 2021 - neoplasm of duodenum C253 Malignant neoplasm of pancreatic duct C240 Malignant neoplasm of extrahepatic … bile duct C254 Malignant neoplasm of endocrine pancreas C241 Malignant neoplasm of ampulla of … vater C257 Malignant neoplasm of other parts of pancreas C250 Malignant neoplasm of head of pancreas … C258 Malignant neoplasm of overlapping sites of pancreas C251 Malignant neoplasm of body of pancreas … C259 Malignant neoplasm of pancreas, unspecified C252 Malignant neoplasm of tail of pancreas Pancreatic
  3. www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/webinars/cahps-cancer-care-yost.pdf
    June 13, 2017 - Introducing the CAHPS Cancer Care Survey ©2017 MFMER | slide-32 CAHPS Cancer Care Survey Sampling … • Received radiation therapy, drug therapy, or surgery for cancer at the specified cancer center … Cancer Surgery • See the document “Fielding the CAHPS® Cancer Care Survey” for specific algorithms … MFMER | slide-38 Sampling Recommendations • Multiple criteria must be met ICD-10 CM diagnosis of malignantneoplasm and The diagnosis is associated with (i.e., on the same billing line) a cancer treatment
  4. hcup-us.ahrq.gov/reports/natstats/his95/table1.pdf
    February 11, 2011 - $6,191 $11,638 $21,778 9.1 14.0 36.0 65 2.13 Malignant neoplasm without specification of site [43.] … neoplasms 363,200 1.04 $10,412 $5,521 $7,779 $11,203 3.8 0.2 11.9 48 2.16.1 Benign neoplasm of uterus … [47.] 149,120 0.43 $13,538 $5,471 $8,625 $14,927 4.9 0.4 29.0 53 2.16.2.1 Benign neoplasm of ovary … 37,441 0.11 $8,951 $5,573 $7,570 $10,357 3.5 0.1 0.0 46 2.16.2.2 Benign neoplasm of colon 24,105 0.07 … $10,132 $19,340 $32,879 8.6 1.7 29.7 62 2.16.2.5 Other and unspecified benign neoplasms 62,122 0.18
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/677cVB3_YRhoEd3qakdjuS
    September 01, 2010 - searched by the previous USPSTF re­ view) and 11 November 2009, using the search terms tes­ ticular neoplasmcancer, and 6 specifically designed germ-cell tumors; as a screening test healthy patients polymerase … range, 1 to 19 mo) Assignment to type of surgery was not randomized No difference in short-term tumor … After 5 years of follow-up, only 1 participant received a diagnosis of a testicular germ-cell tumor … High incidence of benign testicular neoplasms diagnosed by ultrasound. J Urol. 2003;170:1783-6.
  6. www.uspreventiveservicestaskforce.org/home/getfilebytoken/bNvmg937mA6ks3n448uEUD
    November 01, 2004 - The MEDLINE search strategy combined the exploded MeSH heading of oral neoplasm with lip neoplasm, tongue … neoplasm, and pharynx neoplasm and crossed the result with mass screening, yielding 88 articles. … A second search was conducted crossing the exploded MeSH headings of mouth neoplasms or oral cancer with … Forty-seven cancers (7 resultant deaths) were diagnosed in the intervention group and 16 cancers (9 resultant … Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy
  7. effectivehealthcare.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
    July 21, 2014 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … Stage T4b cancer, in which the tumor has spread to the pelvis or abdominal wall, bladder cancer involving … Approximately 25 percent of newly diagnosed bladder cancers present as stage 2 or higher tumors. 6 Once … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … and Treatment of Non-metastatic Muscle-invasive Bladder Cancer exp Urinary Bladder Neoplasms/ (42649
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/L5UwXoftg4JHw4buVDhjUT
    October 01, 2010 - tissue) tumors. … 25% present as invasive tumors (12). … invasive tumor (7). … Evidence on the natural history of asymptomatic bladder cancer is lacking because tumors are typically … tumor marker.
  9. hcup-us.ahrq.gov/reports/statbriefs/sb68.pdf
    March 01, 2009 - About 40 percent of these brain tumors are malignant.1 Cancerous brain tumors can grow rapidly and … Specific locations of brain cancers Table 2 shows the percentage of hospital stays for brain cancer … ) and higher rates for infratentorial tumors, or tumors in the lower brain (cerebellar and brain stem … In general, frontal lobe tumor hospitalizations decrease with age while temporal and parietal lobe tumor … and radiotherapy (6.0 percent), secondary malignancies (1.0 percent), and other cancers (0.9 percent
  10. effectivehealthcare.ahrq.gov/products/prostate-cancer-radiation/research
    November 30, 2012 - outcomes, especially in higher risk tumors, although evidence is lacking. … Prior examinations of the same database have shown tumor characteristics such as size or stage to be … Higher doses of CRT are associated with lower tumor recurrence rates. … If CRT becomes less accessible, we may expect IMRT use to increase in other tumors, perhaps even in tumors … Monitoring IMRT use should be a priority for these other cancers as well as for groups of prostate cancer
  11. effectivehealthcare-admin.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research-protocol
    December 01, 2020 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … . 7 As many as 70 percent of Non-MIBC tumors will recur after initial treatment, with a 10-20 percent … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … and Treatment of Non-metastatic Muscle-invasive Bladder Cance r exp Urinary Bladder Neoplasms/ … or 28 (215263) 7 and 29 (231) 9 or 11 or 20 or 22 or 24 or 26 or 30 (2005) exp Urinary Bladder Neoplasms
  12. effectivehealthcare-admin.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
    December 01, 2020 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … Stage T4b cancer, in which the tumor has spread to the pelvis or abdominal wall, bladder cancer involving … Approximately 25 percent of newly diagnosed bladder cancers present as stage 2 or higher tumors. 6 Once … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … and Treatment of Non-metastatic Muscle-invasive Bladder Cancer exp Urinary Bladder Neoplasms/ (42649
  13. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review79/ovarian-cancer-screening-2004
    May 15, 2004 - Although several other tumor markers have been associated with ovarian cancer, they have not been widely … Treatment of diagnosed cancers includes surgery and chemotherapy or other adjuvant therapy for tumors … Approximately 65 percent of tumors in this study were stage I. … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. … Tumors in the lower pelvis as imaged by sonography. Gynecol Oncol 1990;37:224-9.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
    October 01, 2014 - Executive Summary Background and Objectives Hepatocellular carcinoma (HCC) is the most common primary malignantneoplasm of the liver, usually developing in individuals with chronic liver disease or cirrhosis. … Worldwide, it is the fifth most common cancer and the third most common cause of cancer death.1 There … National Cancer Institute. Liver Cancer. www.cancer.gov/ cancertopics/types/liver. … SEER Cancer Statistics Review, 1975-2010.
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
    October 01, 2014 - Executive Summary Background and Objectives Hepatocellular carcinoma (HCC) is the most common primary malignantneoplasm of the liver, usually developing in individuals with chronic liver disease or cirrhosis. … Worldwide, it is the fifth most common cancer and the third most common cause of cancer death.1 There … National Cancer Institute. Liver Cancer. www.cancer.gov/ cancertopics/types/liver. … SEER Cancer Statistics Review, 1975-2010.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
    November 28, 2012 - Unlike most solid tumors, the future incidence of and mortality rate due to HCC are projected to increase … using the following string of search terms: "Carcinoma, Hepatocellular"[Mesh] OR (hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … comparative studies, and case series by using the following string of search terms: hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma) AND (unresectable OR nonresectable OR inoperable OR irresectable
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
    November 28, 2012 - Unlike most solid tumors, the future incidence of and mortality rate due to HCC are projected to increase … using the following string of search terms: "Carcinoma, Hepatocellular"[Mesh] OR (hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … comparative studies, and case series by using the following string of search terms: hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma) AND (unresectable OR nonresectable OR inoperable OR irresectable
  18. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-non-muscle-invasive-bladder-cancer
    October 03, 2012 - , cystoscopy, urine cytology, urine-based biomarkers, transurethral resection of bladder tumor (TURBT … How do tumor characteristics (stage, grade, multiplicity, size, molecular and genetic alterations) predict … perhaps replace cytology and cystoscopy in the diagnosis and surveillance of patients with urothelial cancers … Genetic and epidemiological evidence indicates that African Americans may have a more aggressive form of malignancy … for 90% of all malignant tumors.
  19. www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/surg-eng-cancer-553a.pdf
    October 07, 2016 - CAHPS Cancer Care Survey: Cancer Surgery CAHPS® Cancer Care Survey Version: Cancer Surgery … Cancer surgery is an operation to remove tissue or part of the body to diagnose cancer, to treat cancer … involved with your cancer surgery through this cancer center. … related to your cancer or cancer surgery? … Besides cancer surgery, did you receive other types of cancer treatments or services from this cancer
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
    May 01, 2013 - One study reported cancer-free survival (from time of study treatment to local tumor progression), extrahepatic … Authors varied in how these tumor characteristics were described: mean number and size of tumors, median … number and size of tumors, range of number and size of tumors, percent solitary and nonsolitary tumors … Hepatobiliary Cancers. Version 2. 2010. … Treatment of large and/ or multiple hepatic malignancies: open surgical approaches of radiofrequency